Alterations in local thyroid hormone signaling in the hippocampus of the SAMP8 mouse at younger ages: Association with delayed myelination and behavioral abnormalities

Journal of Neuroscience Research

Volumn 91, Issue 3, 2013, Pages 382-392

  Sawano, Erika ^a   Negishi, Takayuki ^a   Aoki, Tomoyuki ^b   Murakami, Masami ^b   Tashiro, Tomoko ^a  

^a AOYAMA GAKUIN UNIVERSITY   (Japan)

^b GUNMA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Hippocampus; Hyperactivity; Myelin basic protein; SAMP8; Thyroid hormone; Type 2 deiodinase

Indexed keywords

BRAIN PROTEIN; DEIODINASE; IODIDE PEROXIDASE; LIOTHYRONINE; MYELIN BASIC PROTEIN; THYROID HORMONE; THYROXINE; UNCLASSIFIED DRUG;

AGED; AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR DISORDER; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; EMOTION; ENZYME ACTIVITY; GENETIC TRANSCRIPTION; HIPPOCAMPUS; HORMONE METABOLISM; HYPOTHYROIDISM; IMMUNOHISTOCHEMISTRY; LEARNING DISORDER; MALE; MEMORY DISORDER; MENTAL DISEASE; MOUSE; MYELINATION; NERVE DEGENERATION; NEUROPATHOLOGY; NONHUMAN; OPEN FIELD TEST; PASSIVE AVOIDANCE TEST; PRIORITY JOURNAL; SENESCENCE ACCELERATED MOUSE; SIGNAL TRANSDUCTION; THYROID HORMONE BLOOD LEVEL;

AGE FACTORS; AGING; ANIMALS; AVOIDANCE LEARNING; HIPPOCAMPUS; MALE; MICE; MICE, INBRED AKR; MICE, INBRED ICR; MICE, MUTANT STRAINS; NERVE FIBERS, MYELINATED; NEURODEGENERATIVE DISEASES; PSYCHOMOTOR AGITATION; SIGNAL TRANSDUCTION; THYROID HORMONES; TRIIODOTHYRONINE;

EID: 84872614351     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.23161     Document Type: Article

References (43)

1. Arrojo e Drigo R, Bianco AC. 2011. Type 2 deiodinase at the crossroads of thyroid hormone action. Int J Biochem Cell Biol 43: 1432-1441.
2. Bernal J. 2005. Thyroid hormones and brain development. Vitam Horm 71: 95-122.
3. Bradford MM. 1976. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254.
4. Butterfield DA, Poon HF. 2005. The senescence-accelerated prone mouse (SAMP8): a model of age-related cognitive decline with relevance to alterations of the gene expression and protein abnormalities in Alzheimer's disease. Exp Gerontol 40: 774-783.
5. Butterfield DA, Howard BJ, Yatin S, Allen KL, Carney JM. 1997. Free radical oxidation of brain proteins in accelerated senescence and its modulation by N-tert-butyl-alpha-phenylnitrone. Proc Natl Acad Sci U S A 94: 674-678.
6. Calzà L, Fernandez M, Giuliani A, D'Intino G, Pirondi S, Sivilia S, Paradisi M, Desordi N, Giardino L. 2005. Thyroid hormone and remyelination in adult central nervous system: a lesson from an inflammatory-demyelinating disease. Brain Res Rev 48: 339-346.
7. Calzà L, Fernandez M, Giardino L. 2010. Cellular approaches to central nervous system remyelination stimulation: thyroid hormone to promote myelin repair via endogenous stem and precursor cells. J Mol Endocrinol 44: 13-23.
8. Colas D, Cespuglio R, Sarda N. 2005. Sleep wake profile and EEG spectral power in young or old senescence accelerated mice. Neurobiol Aging 26: 265-273.
9. Davis JD, Tremont G. 2007. Neuropsychiatric aspects of hypothyroidism and treatment reversibility. Minerva Endocrinol 32: 49-65.
10. Del Valle J, Duran-Vilaregut J, Manich G, Casadesús G, Smith MA, Camins A, Pallàs M, Pelegrí C, Vilaplana J. 2010. Early amyloid accumulation in the hippocampus of SAMP8 mice. J Alzheimers Dis 19: 1303-1315.
11. Dentice M, Salvatore D. 2011. Deiodinases: the balance of thyroid hormone: local impact of thyroid hormone inactivation. J Endocrinol 209: 273-282.
12. Farsetti A, Mitsuhashi T, Desvergne B, Robbins J, Nikodem VM. 1991. Molecular basis of thyroid hormone regulation of myelin basic protein gene expression in rodent brain. J Biol Chem 266: 23226-23232.
13. Flood JF, Morley JE. 1992. Early onset of age-related impairment of aversive and appetitive learning in the SAM-P/8 mouse. J Gerontol 47: B52-B59.
14. Flood JF, Morley JE. 1993. Age-related changes in footshock avoidance acquisition and retention in senescence accelerated mouse (SAM). Neurobiol Aging 14: 153-157.
15. Freitas BC, Gereben B, Castillo M, Kalló I, Zeöld A, Egri P, Liposits Z, Zavacki AM, Maciel RM, Jo S, Singru P, Sanchez E, Lechan RM, Bianco AC. 2010. Paracrine signaling by glial cell-derived triiodothyronine activates neuronal gene expression in the rodent brain and human cells. J Clin Invest 120: 2206-2217.
16. Gereben B, Zavacki AM, Ribich S, Kim BW, Huang SA, Simonides WS, Zeöld A, Bianco AC. 2008. Cellular and molecular basis of deiodinase-regulated thyroid hormone signaling. Endocr Rev 29: 898-938.
17. Hauser P, Zametkin AJ, Martinez P, Vitiello B, Matochik JA, Mixson AJ, Weintraub BD. 1993. Attention deficit-hyperactivity disorder in people with generalized resistance to thyroid hormone. N Engl J Med 328: 997-1001.
18. Koibuchi N, Chin WW. 2000. Thyroid hormone action and brain development. Trends Endocrinol Metab 11: 123-128.
19. Lamirand A, Pallud-Mothré S, Ramaugé M, Pierre M, Courtin F. 2008. Oxidative stress regulates type 3 deiodinase and type 2 deiodinase in cultured rat astrocytes. Endocrinology 149: 3713-3721.
20. Markowska AL, Spangler EL, Ingram DK. 1998. Behavioral assessment of the senescence-accelerated mouse (SAM P8 and R1). Physiol Behav 64: 15-26.
21. Martínez de Arrieta C, Morte B, Coloma A, Bernal J. 1999. The human RC3 gene homolog, NRGN contains a thyroid hormone-responsive element located in the first intron. Endocrinology 140: 335-343.
22. Meier S, Bräuer AU, Heimrich B, Nitsch R, Savaskan NE. 2004. Myelination in the hippocampus during development and following lesion. Cell Mol Life Sci 61: 1082-1094.
23. Miyamoto M, Kiyota Y, Yamazaki N, Nagaoka A, Matsuo T, Nagawa Y, Takeda T. 1986. Age-related changes in learning and memory in the senescence-accelerated mouse (SAM). Physiol Behav 38: 399-406.
24. Miyamoto M, Kiyota Y, Nishiyama M, Nagaoka A. 1992. Senescence-accelerated mouse (SAM): age-related reduced anxiety-like behavior in the SAM-P/8 strain. Physiol Behav 51: 979-985.
25. Murakami M, Tanaka K, Greer MA, Mori M. 1988. Anterior pituitary type II thyroxine 5′-deiodinase activity is not affected by lesions of the hypothalamic paraventricular nucleus which profoundly depress pituitary thyrotropin secretion. Endocrinology 123: 1676-1681.
26. Negishi T, Kawasaki K, Sekiguchi S, Ishii Y, Kyuwa S, Kuroda Y, Yoshikawa Y. 2005. Attention-deficit and hyperactive neurobehavioural characteristics induced by perinatal hypothyroidism in rats. Behav Brain Res 159: 323-331.
27. Nomura Y, Yamanaka Y, Kitamura Y, Arima T, Ohnuki T, Oomura Y, Sasaki K, Nagashima K, Ihara Y. 1996. Senescence-accelerated mouse. Neurochemical studies on aging. Ann N Y Acad Sci 786: 410-418.
28. Oppenheimer JH, Schwartz HL. 1997. Molecular basis of thyroid hormone-dependent brain development. Endocr Rev 18: 462-475.
29. Potter GB, Zarach JM, Sisk JM, Thompson CC. 2002. The thyroid hormone-regulated corepressor hairless associates with histone deacetylases in neonatal rat brain. Mol Endocrinol 16: 2547-2560.
30. Siesser WB, Cheng SY, McDonald MP. 2005. Hyperactivity, impaired learning on a vigilance task, and a differential response to methylphenidate in the TRbetaPV knock-in mouse. Psychopharmacology 181: 653-663.
31. Siesser WB, Zhao J, Miller LR, Cheng SY, McDonald MP. 2006. Transgenic mice expressing a human mutant beta1 thyroid receptor are hyperactive, impulsive, and inattentive. Genes Brain Behav 5: 282-297.
32. Simic N, Asztalos EV, Rovet J. 2009. Impact of neonatal thyroid hormone insufficiency and medical morbidity on infant neurodevelopment and attention following preterm birth. Thyroid 19: 395-401.
33. Simonides WS, Mulcahey MA, Redout EM, Muller A, Zuidwijk MJ, Visser TJ, Wassen FW, Crescenzi A, da-Silva WS, Harney J, Engel FB, Obregon MJ, Larsen PR, Bianco AC, Huang SA. 2008. Hypoxia-inducible factor induces local thyroid hormone inactivation during hypoxic-ischemic disease in rats. J Clin Invest 118: 975-983.
34. Takahashi M, Negishi T, Tashiro T. 2008. Identification of genes mediating thyroid hormone action in the developing mouse cerebellum. J Neurochem 104: 640-652.
35. Takahashi M, Negishi T, Imamura M, Sawano E, Kuroda Y, Yoshikawa Y, Tashiro T. 2009. Alterations in gene expression of glutamate receptors and exocytosis-related factors by a hydroxylated-polychlorinated biphenyl in the developing rat brain. Toxicology 257: 17-24.
36. Takeda T. 2009. Senescence-accelerated mouse (SAM) with special references to neurodegeneration models, SAMP8 and SAMP10 mice. Neurochem Res 34: 639-659.
37. Takeda T, Hosokawa M, Takeshita S, Irino M, Higuchi K, Matsushita T, Tomita Y, Yasuhira K, Hamamoto H, Shimizu K, Ishii M, Yamamuro T. 1981. A new murine model of accelerated senescence. Mech Aging Dev 17: 183-194.
38. Tanaka J, Okuma Y, Tomobe K, Nomura Y. 2005. The age-related degeneration of oligodendrocytes in the hippocampus of the senescence-accelerated mouse (SAM) P8: a quantitative immunohistochemical study. Biol Pharm Bull 28: 615-618.
39. Tha KK, Okuma Y, Miyazaki H, Murayama T, Uehara T, Hatakeyama R, Hayashi Y, Nomura Y. 2000. Changes in expressions of proinflammatory cytokines IL-1beta, TNF-alpha and IL-6 in the brain of senescence-accelerated mouse (SAM) P8. Brain Res 885: 25-31.
40. Tomobe K, Nomura Y. 2009. Neurochemistry, neuropathology, and heredity in SAMP8: a mouse model of senescence. Neurochem Res 34: 660-669.
41. Tomobe K, Shinozuka T, Kuroiwa M, Nomura Y. 2012. Age-related changes of Nrf2 and phosphorylated GSK-3β in a mouse model of accelerated aging (SAMP8). Arch Gerontol Geriatr 54: e1-e7.
42. Williams GR. 2008. Neurodevelopmental and neurophysiological actions of thyroid hormone. J Neuroendocrinol 20: 784-794.
43. Yagi H, Katoh S, Akiguchi I, Takeda T. 1988. Age-related deterioration of ability of acquisition in memory and learning in senescence accelerated mouse: SAM-P/8 as an animal model of disturbances in recent memory. Brain Res 474: 86-93.